CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

Data presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions 2025- -Phase 1 ...

Major cholesterol drug recalled over ‘failed dissolution’: What patients must know

Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.
European Medical Journal

Oral JAK Inhibitors Linked to Elevated Lipid Levels

A meta-analysis reveals that oral Janus kinase inhibitors elevate LDL and HDL cholesterol, underscoring the need for lipid monitoring in patients receiving JAK inhibitor therapy.

Manage heart disease without pills or diet? Single treatment to cut bad cholesterol in half

Scientists have discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad ...